Reviewed by Michael Gill, B. Sc.
25 Scar Clinical Trials Near Me
Top Hospitals for Scar Clinical Trials
Image of Henry Ford Health System in Michigan.
Henry Ford Health System
Detroit
3Active Trials
3All Time Trials for Scar
2007First Scar Trial
Image of Northwestern University Feinberg School of Medicine, Department of Dermatology in Illinois.
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago
3Active Trials
2All Time Trials for Scar
2007First Scar Trial
Top Cities for Scar Clinical Trials
Image of Chicago in Illinois.
Chicago
10Active Trials
Northwestern University Feinberg School of Medicine, Department of DermatologyTop Active Site
Image of New York in New York.
New York
8Active Trials
New York Laser & Skin CareTop Active Site
Scar Clinical Trials by Phase of Trial
Phase 1 Scar Clinical Trials
7Active Scar Clinical Trials
7Number of Unique Treatments
10Number of Active Locations
Most Recent Scar Clinical Trials
Top Treatments for Scar Clinical Trials
Treatment Name
Active Scar Clinical Trials
All Time Trials for Scar
First Recorded Scar Trial
hydrocolloid dressing arm
1
1
2022
Microneedling
1
3
2014
Neodyne Device
1
1
2022
Dupilumab
1
1
2022
SCART radiation therapy
1
1
2021

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 27th, 2021

Last Reviewed: October 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004 Jun;113(7):1960-5; discussion 1966-7. https://pubmed.ncbi.nlm.nih.gov/152531842 van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005 Aug;116(2):514-22. https://pubmed.ncbi.nlm.nih.gov/160796833 Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003 May 25;1:17. https://pubmed.ncbi.nlm.nih.gov/128014174 Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006 Jan;26(1):17-31. Epub 2005 Sep 30. Review. https://pubmed.ncbi.nlm.nih.gov/161991195 Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000 Sep;93(3):858-75. Review. https://pubmed.ncbi.nlm.nih.gov/109693226 Fearmonti R, Bond J, Erdmann D, Levinson H. A review of scar scales and scar measuring devices. Eplasty. 2010 Jun 21;10:e43. https://pubmed.ncbi.nlm.nih.gov/205962337 Zhu M, Zhou Z, Chen Y, Schreiber R, Ransom JT, Fraser JK, Hedrick MH, Pinkernell K, Kuo HC. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg. 2010 Feb;64(2):222-8. doi: 10.1097/SAP.0b013e31819ae05c. https://pubmed.ncbi.nlm.nih.gov/200981108 Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Mathews TJ. Births: Final Data for 2015. Natl Vital Stat Rep. 2017 Jan;66(1):1. https://pubmed.ncbi.nlm.nih.gov/281351889 Schmidt NB, Capron DW, Raines AM, Allan NP. Randomized clinical trial evaluating the efficacy of a brief intervention targeting anxiety sensitivity cognitive concerns. J Consult Clin Psychol. 2014 Dec;82(6):1023-33. doi: 10.1037/a0036651. Epub 2014 May 12. https://pubmed.ncbi.nlm.nih.gov/2482109610 Pomerantz H, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin G, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri J, Lew R, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial. JAMA Dermatol. 2015 Sep;151(9):952-60. doi: 10.1001/jamadermatol.2015.0502. https://pubmed.ncbi.nlm.nih.gov/25950503